NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
30
AWH Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
20.66%
Day range:
$0.71 - $0.79
52-week range:
$0.67 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.11x
P/B ratio:
--
Volume:
79.3K
Avg. volume:
77.6K
1-year change:
-69.85%
Market cap:
$13.2M
Revenue:
$9.2M
EPS (TTM):
-$1.20
Analysts' Opinion
-
Consensus RatingAspira Womens Health has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Aspira Womens Health has an estimated upside of 596.2% from its current price of $0.79.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.79.
Fair Value
-
According to the consensus of 0 analysts, Aspira Womens Health has 596.2% upside to fair value with a price target of -- per share.
AWH vs. S&P 500
-
Over the past 5 trading days, Aspira Womens Health has overperformed the S&P 500 by 7.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Aspira Womens Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aspira Womens Health has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Aspira Womens Health reported revenues of $2.3M.
Earnings Growth
-
Aspira Womens Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Aspira Womens Health reported earnings per share of -$0.23.
Enterprise value:
12.6M
EV / Invested capital:
-13.16x
Price / LTM sales:
1.11x
EV / EBIT:
--
EV / Revenue:
1.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.86x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$5.2M
Return On Assets:
-240.12%
Net Income Margin (TTM):
-165.07%
Return On Equity:
--
Return On Invested Capital:
-8215.24%
Operating Margin:
-165.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $7.9M | $9.2M | $9M | $2.2M | $2.3M | |
| Gross Profit | $4.1M | $5.3M | $5.2M | $1.3M | $1.4M | |
| Operating Income | -$35M | -$19.8M | -$17M | -$4.1M | -$3.7M | |
| EBITDA | -$34.7M | -$20.3M | -$16.7M | -$4.1M | -$3.5M | |
| Diluted EPS | -$4.61 | -$2.15 | -$1.20 | -$0.48 | -$0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.3M | $47.2M | $23M | $7.6M | $4.1M | |
| Total Assets | $21.3M | $48M | $23.9M | $8.7M | $4.8M | |
| Current Liabilities | $4.6M | $6.4M | $7.3M | $5.2M | $5.5M | |
| Total Liabilities | $6.7M | $9.5M | $12.8M | $9.3M | $7.3M | |
| Total Equity | $14.6M | $38.5M | $11.2M | -$659K | -$2.5M | |
| Total Debt | $2.2M | $3M | $2.8M | $1.7M | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$31.6M | -$19.5M | -$14.5M | -$3.3M | -$2.9M | |
| Cash From Investing | -$188K | -$86K | -$49K | -- | -$2K | |
| Cash From Financing | $7.5M | $4.2M | $11.4M | $4.2M | $4.1M | |
| Free Cash Flow | -$31.8M | -$19.6M | -$14.6M | -$3.3M | -$2.9M | |
AWH
Sector
Market Cap
$13.2M
$43.9M
Price % of 52-Week High
13.98%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
-20.39%
-0.74%
1-Year Price Total Return
-69.85%
-29.11%
Beta (5-Year)
1.389
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.75
200-day SMA
Sell
Level
$1.70
Bollinger Bands (100)
Sell
Level
0.76 - 1.04
Chaikin Money Flow
Sell
Level
-60.8M
20-day SMA
Buy
Level
$0.77
Relative Strength Index (RSI14)
Buy
Level
51.60
ADX Line
Sell
Level
7.14
Williams %R
Neutral
Level
-47.619
50-day SMA
Sell
Level
$0.82
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
20.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-121.2989)
Sell
CA Score
(Annual)
Level (-8.7518)
Buy
Beneish M-Score
(Annual)
Level (-2.9188)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (15.3241)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Stock Forecast FAQ
In the current month, AWH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AWH average analyst price target in the past 3 months is --.
-
Where Will Aspira Womens Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aspira Womens Health share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Aspira Womens Health?
Analysts are divided on their view about Aspira Womens Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aspira Womens Health is a Sell and believe this share price will drop from its current level to --.
-
What Is Aspira Womens Health's Price Target?
The price target for Aspira Womens Health over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AWH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aspira Womens Health is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AWH?
You can purchase shares of Aspira Womens Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aspira Womens Health shares.
-
What Is The Aspira Womens Health Share Price Today?
Aspira Womens Health was last trading at $0.75 per share. This represents the most recent stock quote for Aspira Womens Health. Yesterday, Aspira Womens Health closed at $0.79 per share.
-
How To Buy Aspira Womens Health Stock Online?
In order to purchase Aspira Womens Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
